The Hemorrhoids drugs in development market research report provides comprehensive information on the therapeutics under development for Hemorrhoids, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Hemorrhoids. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Hemorrhoids and features dormant and discontinued products.
GlobalData tracks seven drugs in development for Hemorrhoids by six companies/universities/institutes. The top development phase for Hemorrhoids is phase ii with four drugs in that stage. The Hemorrhoids pipeline has seven drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Hemorrhoids pipeline products market are: AVVA Rus, Shanghai Pharmaceuticals and Stelis Biopharma.
The key targets in the Hemorrhoids pipeline products market include Voltage Gated Sodium Channel (SCN), Cysteinyl Leukotriene Receptor 1, and Alpha 1 Adrenergic Receptor.
The key mechanisms of action in the Hemorrhoids pipeline product include Cysteinyl Leukotriene Receptor 1 Antagonist with two drugs in Phase I. The Hemorrhoids pipeline products include three routes of administration with the top ROA being Rectal and one key molecule types in the Hemorrhoids pipeline products market including Small Molecule.
Hemorrhoids overview
Hemorrhoids occur when the veins in and around the anus and lower rectum become swollen and irritated. This happens when there is extra pressure on these veins. Hemorrhoids can be either inside your anus (internal) or under the skin around your anus (external). Hemorrhoids are very common in both men and women; about half of all people will have hemorrhoids by age 50.
For a complete picture of Hemorrhoids’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
